Trial Profile
Ledipasvir plasma trough concentrations in patients with decompensated cirrhosis receiving Sofosbuvir-Ledipasvir treatment for hepatitis-C genotype 1 infection
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Ledipasvir (Primary) ; Sofosbuvir
- Indications Hepatitis C
- Focus Pharmacokinetics
- 12 May 2016 New trial record
- 17 Apr 2016 Preliminary results presented at The International Liver Congress™ 2016